Rosetting T Cells in Hodgkin Lymphoma Are Activated by Immunological Synapse Components HLA Class II and CD58
Overview
Authors
Affiliations
A unique feature of Hodgkin lymphoma (HL) is the presence of CD4+ T cells that surround, protect, and promote survival of tumor cells. The adhesion molecules involved in this so-called T-cell rosetting are important components of the immunological synapse (IS). However, it is unknown whether this synapse is fully assembled and leads to T-cell activation by enabling interaction between the T-cell receptor (TCR) and human leukocyte antigen class II (HLA-II). We established a novel rosetting model by coculturing HLA-II-matched peripheral blood mononuclear cells with HL cell lines and showed IS formation with activation of rosetting T cells. HLA-II downregulation by class II transactivator knockout did not affect the extent of rosetting, but almost completely abrogated T-cell activation. Intriguingly, the level of CD58 expression correlated with the extent of rosette formation, and CD58 knockout or CD2 blockade reduced both rosette formation and T-cell activation. The extension of our findings to primary HL tissue by immunohistochemistry and proximity ligation assays showed interaction of CD2 with CD58 and of TCR-associated CD4 with HLA-II. In conclusion, T-cell rosetting in HL is established by formation of the IS, and activation of rosetting T cells critically depends on the interaction of both TCR-HLA-II and CD2-CD58.
Cancer ATF4-mediated CD58 endocytosis impairs anti-tumor immunity and immunotherapy.
Zeng H, Yu J, Wang H, Shen M, Zou X, Zhang Z J Transl Med. 2025; 23(1):225.
PMID: 40001116 PMC: 11863482. DOI: 10.1186/s12967-025-06245-4.
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2.
Jo Y, Sim H, Yun B, Park Y, Jin H Exp Mol Med. 2024; 56(10):2113-2126.
PMID: 39349829 PMC: 11541569. DOI: 10.1038/s12276-024-01317-9.
Implicit Flow Cytometric Diagnosis of Classic Hodgkin Lymphoma Using CD3CD4CD26 T-Cells.
Gravenmier C, Song J, Shao H J Clin Lab Anal. 2024; 38(17-18):e25096.
PMID: 39235202 PMC: 11484709. DOI: 10.1002/jcla.25096.
Gunawardana J, Law S, Sabdia M, Fennell E, Hennessy A, Leahy C Am J Hematol. 2024; 99(11):2096-2107.
PMID: 39152767 PMC: 11469944. DOI: 10.1002/ajh.27459.
Chantziou A, Brenna C, Ioannidou K, Chen O, Korkolopoulou P, Antoniadou A Blood Adv. 2024; 8(24):6215-6231.
PMID: 39116294 PMC: 11697195. DOI: 10.1182/bloodadvances.2023012116.